skip to content

Emmaus Medical Announces Completion of All Patient Visits For Its Phase 3 Clinical Trial For Treatment of Sickle Cell Disease

January 07, 2014

Emmaus Medical, Inc. today announced it has completed all patient visits for its Phase 3 clinical trial for the treatment of sickle cell disease. Emmaus expects top-line data from the Phase 3 clinical trial to be available in the first quarter of 2014.